A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.
Haemonetics Corporation HAE
Mixed broader-coverage candidate · Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital.
On FrontierLab's discovery record since 2026-06-18 (15 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)
Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Mixed" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-09-09), not the curated Frontier signal.
⚠ Pump risk: parabolic/spike characteristics detected in the screen flags. Treat any positive grade with extra skepticism.
Key quality signals
| Revenue growth (YoY) | 0.4% |
|---|---|
| Gross margin | 57.4% |
| Gross profits / assets | 0.33 |
| Rule of 40 | 18.6 |
| Net margin | 18.2% |
| Cash runway (months) | — |
| PEG | — |
| Price / sales | 3.5 |
Quality checklist
- ✗ Revenue growth — 0.4% (pass ≥ 20%)
- ✓ Gross profits / assets — 0.33 (pass ≥ 0.33)
- ~ Gross margin — 57.4% (pass ≥ 60%)
- ✓ Cash generation
- ✓ Share dilution — -5.5%
Fundamentals — snapshot as of 2026-09-09
| Stage | Established |
|---|---|
| Share issuance (YoY) | -5.5% · buying back shares |
| Moat | — |
| TAM | — |
| P/E (trailing) | 50.4 |
| EPS (trailing) | $2.04 |
| Burn multiple | — |
| Gross-margin trend (pts) | 0.6 |
| Cash / assets | 0.09 |
| Net debt / EBITDA | 3.6 |
| Statements as of | Q1 FY2027 · filed 2026-08-06 |
Momentum context — a snapshot from 2026-09-09, not current
| Price at surface | $102.84 (as of 2026-09-09) |
|---|---|
| 52-week range | $47.32 – $109.57 |
| % off 52-wk high | -6.1% |
| RSI (14) | 65 |
| Relative volume | 0.8× |
Risk flags
← All broader-coverage names · Curated names → · Open the interactive screener →
Data as of 2026-09-09 (end-of-day). How grades are computed →